Antiretroviral Management
  • Featured content
    In this downloadable slideset, Kenneth Mayer, MD, and Program Director Joseph J. Eron, Jr., MD, review key data and optimal approaches for pre- and post-exposure prophylaxis in patients at risk for HIV infection.

    Topics include:
    • HIV-uninfected gay man at risk for HIV infection
    • Heterosexual HIV-discordant couple
    • HIV-uninfected woman with substance use at risk for HIV infection
    • Practical Considerations
    Date Posted: 6/28/2017
  • Featured content
    Led by Kathleen E. Squires, MD, a panel of experts discusses their approach to management and prevention of HIV infection in complex clinical scenarios.
  • Featured content
    Led by Joseph J. Eron, Jr., MD, a panel of experts discusses how they approach current controversies related to the management of patients with HIV infection.
  • Featured content
    In this downloadable slideset, Joel E. Gallant, MD, MPH, provides a comprehensive update on ART management.
    Date Posted: 3/29/2017
  • Featured content
    José R. Arribas, MD, discusses the rationale for and clinical trial data on the modification of virologically suppressive antiretroviral therapy regimens, including important considerations for individualized decision making.
  • 1
  • 2
  • 3
  • 4
  • 5

Latest Content

10 of 357 Shown
  • Contemporary Management of HIV: Antiretroviral Therapy as Prevention

    In this downloadable slideset, Kenneth Mayer, MD, and Program Director Joseph J. Eron, Jr., MD, review key data and optimal approaches for pre- and post-exposure prophylaxis in patients at risk for HIV infection.

    Topics include:
    • HIV-uninfected gay man at risk for HIV infection
    • Heterosexual HIV-discordant couple
    • HIV-uninfected woman with substance use at risk for HIV infection
    • Practical Considerations
    Date Posted: 6/28/2017
  • Weighing Boosted vs Unboosted Options for a Patient With Comorbidities Who Desires an STR

    Eric S. Daar MD - 6/21/2017
    What is the optimal ART regimen for a patient with CKD and CVD who desires an STR?
  • Optimizing ART for a Patient With PI Intolerance and a History of Resistance and Nonadherence

    Eric S. Daar MD - 6/21/2017 1 comment / Last Comment: 6/22/2017
    Would you switch a virologically suppressed patient who is experiencing PI toxicity to a PI-sparing regimen if they had history of nonadherence and resistance?
  • Weighing Boosted vs Unboosted Options for a Patient Who Requires Treatment Prior to Availability of Resistance Data

    Eric S. Daar MD - 6/21/2017
    For a newly-diagnosed patient with an OI and pending resistance test results, when and with what would you recommend initiating ART?
  • Contemporary Management of HIV: To Boost or Not to Boost: Advantages and Disadvantages of Boosted ART

    In this downloadable slideset, Eric S. Daar, MD, and Program Director Joseph J. Eron, Jr., MD, review advantages and disadvantages of boosted ART regimens for managing patients with HIV.
    Date Posted: 6/16/2017
  • Selecting ART for an Aging Patient With Multiple Comorbidities and Potential Drug–Drug Interactions

    David A. Wohl MD - 5/31/2017
    In an older patient managing hypertension, reactive airways disease, and moderate renal insufficiency, what ART regimen would you recommend?
  • ART Switch for Comorbidities in a Middle-Aged Black Woman

    Lisa Hightow-Weidman MD, MPH - 5/12/2017 1 comment / Last Comment: 6/16/2017
    One-tablet regimens may not always be the best choice of ART, but the best choice is always the one the patient is willing to take.
  • Initiating ART in a Hispanic MSM With Fear of Stigma and History of Depression

    Lisa Hightow-Weidman MD, MPH - 5/12/2017
    Understanding a patient’s life circumstances may be as important as any other aspect of providing good care.
  • Optimizing HIV Care Engagement for a Newly Diagnosed Young Black Man

    Lisa Hightow-Weidman MD, MPH - 5/12/2017
    In some cases, gaining trust may be the most important aspect of a patient’s care.
  • Contemporary Management of HIV: Best Practices for ART Management and Optimizing Outcomes in Persons of Color

    In this downloadable slideset, Lisa Hightow-Weidman, MD, MPH, and Program Director Eric S. Daar, MD, review key data and offer evidence-based guidance on linking and retaining persons of color in HIV care.
    Date Posted: 5/9/2017
10 of 357 Shown
Show 10 More
Loading...